Achieving Data Diversity Through AI in Drug Development

AI could revolutionise drug discovery but experts are calling for ethical and social justice issues to be addressed now, e.g. anonymity of data, underrepresented groups and the current consent system. AI could help researchers fine-tune patient responses to medication and reduce the cost of drug discovery, but healthcare data breaches could pose a risk. Synthetic patient records could be a solution, but even with patient consent, implications must be understood.